Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria.
Saved in:
| Title: | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria. |
|---|---|
| Authors: | Won, Chong Hyun1 (AUTHOR), Park, Chun Wook2 (AUTHOR), Ahn, Jiyoung3 (AUTHOR), Ko, Joo Yeon4 (AUTHOR), Cho, Sang Hyun5 (AUTHOR), Lee, Yang Won6 (AUTHOR), Lee, Joo Hee7 (AUTHOR), Ng, Khai Jing7 (AUTHOR), Hong, Min Young7 (AUTHOR), Zhong, Jinglin8 (AUTHOR), Dossenbach, Martin7 (AUTHOR), Son, Sang Wook9 (AUTHOR) skin4u@korea.ac.kr |
| Source: | JEADV Clinical Practice. Jun2026, Vol. 5 Issue 2, p529-537. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 27686566 |
|---|---|
| DOI: | 10.1002/jvc2.70271 |
